RCT of Tocilizumab for Anti-MDA5+DM

Clinical trial NCT07377058 · RECRUITING

Trial details

NCT number: NCT07377058
Sponsor: Peking Union Medical College Hospital
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Dermatomyositis

Start date: 2025-11-01
Primary completion: 2026-10-01
Enrollment: 110

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.